skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A Rational Approach for Discovering and Validating Cancer Markers in Very Small Samples Using Mass Spectrometry and ELISA Microarrays

Journal Article · · Disease Markers
DOI:https://doi.org/10.1155/2004/754640· OSTI ID:1197934
 [1];  [1];  [2];  [1]
  1. Pacific Northwest National Laboratory, Richland, WA, USA
  2. University of California School of Nursing, Los Angeles, CA, USA

Identifying useful markers of cancer can be problematic due to limited amounts of sample. Some samples such as nipple aspirate fluid (NAF) or early-stage tumors are inherently small. Other samples such as serum are collected in larger volumes but archives of these samples are very valuable and only small amounts of each sample may be available for a single study. Also, given the diverse nature of cancer and the inherent variability in individual protein levels, it seems likely that the best approach to screen for cancer will be to determine the profile of a battery of proteins. As a result, a major challenge in identifying protein markers of disease is the ability to screen many proteins using very small amounts of sample. In this review, we outline some technological advances in proteomics that greatly advance this capability. Specifically, we propose a strategy for identifying markers of breast cancer in NAF that utilizes mass spectrometry (MS) to simultaneously screen hundreds or thousands of proteins in each sample. The best potential markers identified by the MS analysis can then be extensively characterized using an ELISA microarray assay. Because the microarray analysis is quantitative and large numbers of samples can be efficiently analyzed, this approach offers the ability to rapidly assess a battery of selected proteins in a manner that is directly relevant to traditional clinical assays.

Sponsoring Organization:
USDOE
Grant/Contract Number:
ACO6-76RLO 1830
OSTI ID:
1197934
Journal Information:
Disease Markers, Journal Name: Disease Markers Vol. 20 Journal Issue: 3; ISSN 0278-0240
Publisher:
Hindawi Publishing CorporationCopyright Statement
Country of Publication:
Country unknown/Code not available
Language:
English
Citation Metrics:
Cited by: 17 works
Citation information provided by
Web of Science

Similar Records

A rational approach for discovering and validating cancer markers in very small samples using mass spectrometry and ELISA microarrays
Journal Article · Fri Oct 01 00:00:00 EDT 2004 · Disease Markers · OSTI ID:1197934

ELISA microarray technology as a high-throughput system for cancer biomarker validation
Journal Article · Sun Jan 01 00:00:00 EST 2006 · Expert Review of Proteomics · OSTI ID:1197934

Development and Validation of Sandwich ELISA Microarrays with Minimal Assay Interference
Journal Article · Sun Jun 01 00:00:00 EDT 2008 · Journal of Proteome Research, 7(6):2406-2414 · OSTI ID:1197934

Related Subjects